Parenteral Packaging Market Size, Share & Industry Analysis, By Material (Plastic, Glass, and Paper & Paperboard), By Product Type (Bottles, Pre-Fillable Syringes & Cartridges, Vials & Ampoules, Closures, Blister Packs, Bags & Pouches, Boxes & Trays, and Others), By Packaging Type (Primary Packaging, Secondary Packaging, and Tertiary Packaging), and Regional Forecast, 2024-2032

The global parenteral packaging market size was valued at USD 22.98 billion in 2023. The market is projected to grow from USD 24.15 billion in 2024 to USD 39.03 billion by 2032, exhibiting a CAGR of 6.18% during the forecast period.

The global parenteral packaging market is the industry that designs, manufactures, and supplies packaging solutions specifically for parenteral drug delivery systems. Parenteral administration involves delivering medications by bypassing the gastrointestinal tract, typically through injections, including intravenous (IV), intramuscular (IM), and subcutaneous (SC) routes. This form of drug delivery is crucial for medications that require fast action, precise dosing, and drugs that are ineffective or unstable when taken orally. Driven by the increasing prevalence of chronic diseases, advancements in biopharmaceuticals, and technological innovations, the market is poised for significant growth increasing the market share.

The COVID-19 pandemic had a moderate effect on the global market. As the world faced an unprecedented health crisis, the demand for parenteral packaging solutions surged due to increased vaccination efforts, surged consciousness of infectious diseases, and the overall rise in demand for injectable therapeutics. The development and global distribution of COVID-19 vaccines required specialized packaging solutions, such as vials, syringes, and cold chain packaging, to ensure the safety and efficacy of vaccines.

Parenteral Packaging Market Trends

Shift Toward Prefilled Syringes and Self-Administration Devices is Evolving as an Important Trend

The global parenteral packaging market is witnessing a significant shift toward prefilled syringes and self-administration devices, driven by the increasing demand for convenience, safety, and precision in drug delivery. Prefilled syringes offer greater convenience for both healthcare professionals and patients. They come preloaded with the exact dosage of medication, reducing the need for manual preparation and minimizing the risk of dosing errors. This ease of use is particularly beneficial in outpatient settings and home healthcare, where patients may self-administer medications. The adoption of prefilled syringes helps improve patient compliance with treatment regimens, which is critical for managing chronic conditions.

Moreover, advancements in materials and manufacturing processes are driving innovation in prefilled syringe technology. For example, the use of advanced polymers, such as cyclic olefin copolymers (COCs), offers superior strength, clarity, and chemical resistance compared to traditional glass syringes. These materials also provide greater design flexibility, enabling the development of user-friendly and ergonomic syringe designs. All these aspects are predicted to boost the parenteral packaging market growth over the forthcoming years.

Parenteral Packaging Market Growth Factors

Growing Prevalence of Chronic Diseases to Fuel Market Growth

The increasing prevalence of chronic diseases is a significant driver for the market. Chronic conditions, such as diabetes, cancer, and cardiovascular diseases, often require long-term treatment with injectable medications, thereby boosting the demand for parenteral packaging solutions. Diabetes is a major global health issue, affecting millions of people globally. The management of diabetes often involves the use of injectable insulin, which requires safe and effective parenteral packaging. As the incidence of diabetes continues to rise, so does the demand for insulin pens, prefilled syringes, and vials, driving market growth. The global aging population is more susceptible to chronic diseases, leading to increased demand for healthcare services and medications. Older adults often require injectable drugs for the management of chronic conditions, further propelling the demand for parenteral packaging solutions.

Advancements in Biopharmaceuticals are Fueling Market Growth

Biopharmaceuticals, which include biologics and biosimilars, are complex, large-molecule drugs derived from living organisms. They require specialized packaging solutions to maintain their stability, efficacy, and sterility, leading to increased demand for parenteral packaging. Biologics have become an integral part of modern medicine, offering targeted therapies for a range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. As the market for biologics continues to expand, so does the need for advanced parenteral packaging solutions that can preserve the delicate nature of these drugs. These factors are proving to be significant market drivers for the market.

RESTRAINING FACTORS

Stringent Regulatory Requirements and High Cost of Advanced Packaging Solutions are Hindering Market Growth

Stringent regulatory requirements significantly constrain the market. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established comprehensive guidelines to ensure the safety, efficacy, and quality of pharmaceutical packaging. Companies must conduct extensive testing to demonstrate compliance with regulatory standards, which can delay product launches and increase development costs. Implementing advanced packaging technologies requires substantial investments in equipment, research, and development. Smaller pharmaceutical companies may find it challenging to allocate the necessary resources to adopt these technologies, limiting their market participation.

Parenteral Packaging Market Segmentation Analysis

By Material Analysis

Barrier Properties and Chemical Inertness of Plastics are Fostering the Segment Growth

Based on the material, the market is divided into plastic, glass, and paper & paperboard.

The plastic segment dominates the market. Plastic can be easily molded into a wide variety of shapes and sizes, making it ideal for diverse packaging needs, from small vials and blister packs to large containers and sterile barrier systems. It is used for syringes, IV bags, pill bottles, blister packs, and medical device packaging, among others.

Glass is the second-largest segment in the market. Glass is highly inert and non-reactive, making it the preferred raw material for packaging highly sensitive drugs and biologics. It ensures that there is no interaction between the packaging material and the drug, which is critical in maintaining the stability and efficacy of certain parenteral formulations.

By Product Type Analysis

Vials & Ampoules Dominate the Market Due to Their Ease of Use and Cost-Effectiveness

Based on the product type, the market is divided into bottles, pre-fillable syringes & cartridges, vials & ampoules, closures, blister packs, bags & pouches, boxes & trays, and others.

Vials and ampoules are used for a broad spectrum of drugs, including vaccines, antibiotics, and other injectable medications and are dominating in the market. Their versatility makes them suitable for both liquid and lyophilized (freeze-dried) formulations. Available in both glass and plastic, vials and ampoules provide options based on drug stability and compatibility, offering flexibility to pharmaceutical manufacturers.

Pre-fillable syringes & cartridges are the second dominating segment of this market. There is an increasing trend toward prefilled syringes and single-dose packaging, which offers several benefits over traditional multi-dose vials. These options reduce the risk of contamination, improve dosing accuracy, and simplify administration, making them ideal for large-scale vaccination campaigns.

By Packaging Type Analysis

Convenience and Dosage Accuracy of Primary Packaging Products Make them a Leading Segment of the Market

Based on the packaging type, the market is segmented into primary packaging, secondary packaging, and tertiary packaging.

Primary packaging is the leading segment in the global market. Primary packaging safeguards the product from contamination, moisture, light, and other environmental factors that can compromise its efficacy and safety. Primary packaging often includes features that facilitate easy and accurate dispensing of the product. Advances in primary packaging, such as smart packaging with embedded sensors, enhance functionality and patient compliance.

Secondary packaging is the second dominating segment of this market. Secondary packaging provides an extra layer of protection during storage and transportation, reducing the risk of damage. Secondary packaging aids in the efficient handling and distribution of healthcare products.

REGIONAL INSIGHTS

The market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America holds the largest part in the parenteral packaging market share. The region's strong healthcare infrastructure, high prevalence of chronic diseases, and the presence of major pharmaceutical companies drive the demand for advanced packaging solutions.

Europe is the second dominating region in the market. Europe is another key market for parenteral packaging, driven by a robust pharmaceutical sector and a strong focus on regulatory compliance and sustainability.

Asia Pacific is also one of the dominating regions and is set to register substantial growth in the coming years. The Asia Pacific region is the fastest-growing market, driven by increasing healthcare expenditure and industrialization.

Latin America is an emerging market with a growing demand for parenteral packaging driven by improvements in healthcare access and economic development.

The Middle East & Africa region is developing, with significant potential for growth in healthcare packaging due to improving healthcare systems.

KEY INDUSTRY PLAYERS

Key Participants in the Market Witnessing Significant Growth Opportunities

The global parenteral packaging market is extremely competitive and uneven. On the basis of market share, some companies lead the market by introducing cutting-edge packaging solutions. They are engaged in escalating innovation and their customer base in regions. Top players in the market include Amcor Plc, Gerresheimer AG, SCHOTT AG, Berry Global, Inc., West Pharmaceutical Services, Inc., AptarGroup, Inc., SGD Pharma, Oliver Healthcare Packaging, Stevanato Group, Graphic Packaging International, LLC, Adelphi Group, Baxter International Inc., WestRock Company, Tekni-Plex, Inc., Nipro Corporation, and others.

List of Top Parenteral Packaging Companies:

• Amcor Plc (Switzerland)


• Gerresheimer AG (Germany)


• SCHOTT AG (Germany)


• Berry Global, Inc. (U.S.)


• West Pharmaceutical Services, Inc. (U.S.)


• AptarGroup, Inc. (U.S.)


• SGD Pharma (France)


• Oliver Healthcare Packaging (U.S.)


• Stevanato Group (Italy)


• Graphic Packaging International, LLC (U.S.)


• Adelphi Group (U.K.)


• Baxter International Inc. (U.S.)


• WestRock Company (U.S.)


• Tekni-Plex, Inc. (U.S.)


• Nipro Corporation (Japan)

KEY INDUSTRY DEVELOPMENTS:

• August 2023 – Gerresheimer invested around 110.14 million US Dollars in the new building and the new production lines for the plant expansion at its facility in Querétaro, Mexico. The building is expected to be completed by mid-2024, and production is anticipated to start in the second quarter of 2025.


• May 2023 – Schott Pharma launched prefilled syringes made from advanced polymers delivering deep cold drugs. These drugs are stored and transported on dry ice, so syringes are designed from advanced pharmaceutical-grade polymers to protect the drug from contamination.


• February 2023 – Nexus Pharmaceuticals launched a product line of sterile vials, including 20mL clear vials, 10mL clear vials, and 2mL amber vials. These vials are designed for use in healthcare clinics, veterinary offices, and research laboratories.


• February 2023 – Berry Global Healthcare introduced a comprehensive bundle solution to help customers capitalize on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines.


• June 2022 – Nipro invested in the expansion of its production capacity for premium quality glass tubing for the primary pharmaceutical packaging market, with a clear focus on injectable medicines.  Nipro intends to spend over USD 60 million on increasing its capacity in the manufacturing facilities of Aumale, France, and Millville, New Jersey (USA).

REPORT COVERAGE

The market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, competitive landscape, product/service types, Porter’s five forces analysis, and leading end-use industries of the product. Besides, the report offers insights into the market trends and highlights key industry developments. In addition to the above factors, the report encompasses several factors that contributed to the market's growth in recent years.

REPORT SCOPE & SEGMENTATION